Suppliers in Berea, OH
6 Medicare Suppliers found. Showing 1 - 6
 Giant Eagle Pharmacy #2108 Community/Retail Pharmacy Location: 50 W Bridge St, Berea, Ohio 44017 Phone: (440) 826-9104 |
Cvs Pharmacy #03035 Durable Medical Equipment & Medical Supplies Location: 212w Bagley Rd, Berea, Ohio 44017 Phone: (440) 243-6676 |
Walgreens #1234 Durable Medical Equipment & Medical Supplies Location: 6 E Bagley Rd, Berea, Ohio 44017 Phone: (440) 891-9422 |
S A Maher Inc Durable Medical Equipment & Medical Supplies Location: 845 W Bagley Rd, Berea, Ohio 44017 Phone: (440) 777-5544 |
Shirley R. Daniel Od & Terry E. Dan Medicare Supplier Location: 295 High Street, Berea, Ohio 44017 Phone: (440) 234-3800 |
Dr Caitlin S Filips Eyewear Supplier (Equipment, not the service) Location: 487 W Bagley Rd, Berea, Ohio 44017 Phone: (440) 891-1940 |
News Archive
Genentech's Tarceva receives FDA approval as maintenance therapy for advanced NSCLC
Genentech, Inc., a wholly owned member of the Roche Group, announced today that the U.S. Food and Drug Administration approved the daily pill Tarceva® (erlotinib) as a maintenance treatment for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose disease has not progressed after four cycles of platinum-based first-line chemotherapy.
UCI agrees to use MAggPI's web-based digital whole slide imaging to teach medical students
The University of California, Irvine School of Medicine has agreed to use web-based digital whole slide imaging developed by MAggPI in the teaching of medical students. In this collaboration, diagnostic-quality, expert-curated digital images of normal and diseased tissue will be incorporated in the teaching of histology and pathology to medical students at UCI.
Researchers reveal potent new mechanism of action for treatment of IBD
Professor Akiyoshi Fukamizu's research group of Life Science Center for Survival Dynamics, University of Tsukuba, Eisai Co., Ltd. and its gastrointestinal business subsidiary EA Pharma Co., Ltd. have revealed a mechanism in which an analogue (ER-464195-01) of Eisai's in-house discovered E6007 inhibits integrin activation by dissociating interaction between calreticulin (CRT) and integrin α 4 (ITGA4), suppressing adhesion and infiltration of leukocytes overall.
ETI develops extended release SC depot formulation of NSAID drug meloxicam
Encore Therapeutics Inc. has developed a proprietary extended release subcutaneous (SC) depot formulation (ETI-511) of the NSAID drug meloxicam.
Inadequate payments prompt insurance companies to raise premiums, avoid low-income market
Millions of Medicare recipients have been forcibly reassigned to different prescription drug plans because Part D reimbursements to insurance companies covering low-income patients are lower than the actual costs incurred, according to a study released online today by Health Affairs. The report describes how a system designed to encourage competition and to subsidize care for low-income Medicare patients instead has led companies to raise their premiums in an effort to price themselves out of the low-income segment of the Part D market.
› Verified 9 days ago